PLX
Price
$2.39
Change
-$0.04 (-1.65%)
Updated
Feb 21 closing price
Capitalization
175.98M
18 days until earnings call
ZNTL
Price
$2.32
Change
-$0.15 (-6.07%)
Updated
Feb 21 closing price
Capitalization
165.34M
3 days until earnings call
Ad is loading...

PLX vs ZNTL

Header iconPLX vs ZNTL Comparison
Open Charts PLX vs ZNTLBanner chart's image
Protalix BioTherapeutics
Price$2.39
Change-$0.04 (-1.65%)
Volume$536.86K
Capitalization175.98M
Zentalis Pharmaceuticals
Price$2.32
Change-$0.15 (-6.07%)
Volume$1.02M
Capitalization165.34M
PLX vs ZNTL Comparison Chart
Loading...
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLX vs. ZNTL commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLX is a Hold and ZNTL is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (PLX: $2.39 vs. ZNTL: $2.32)
Brand notoriety: PLX and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLX: 88% vs. ZNTL: 47%
Market capitalization -- PLX: $175.98M vs. ZNTL: $165.34M
PLX [@Biotechnology] is valued at $175.98M. ZNTL’s [@Biotechnology] market capitalization is $165.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLX’s FA Score shows that 0 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • PLX’s FA Score: 0 green, 5 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, both PLX and ZNTL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLX’s TA Score shows that 3 TA indicator(s) are bullish while ZNTL’s TA Score has 5 bullish TA indicator(s).

  • PLX’s TA Score: 3 bullish, 5 bearish.
  • ZNTL’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ZNTL is a better buy in the short-term than PLX.

Price Growth

PLX (@Biotechnology) experienced а -11.15% price change this week, while ZNTL (@Biotechnology) price change was -4.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

PLX is expected to report earnings on May 09, 2025.

ZNTL is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLX($176M) has a higher market cap than ZNTL($165M). PLX YTD gains are higher at: 27.128 vs. ZNTL (-23.432). PLX has higher annual earnings (EBITDA): -6.48M vs. ZNTL (-207.96M). ZNTL has more cash in the bank: 391M vs. PLX (27.4M). PLX has less debt than ZNTL: PLX (5.68M) vs ZNTL (40.5M). PLX has higher revenues than ZNTL: PLX (45.7M) vs ZNTL (40.6M).
PLXZNTLPLX / ZNTL
Capitalization176M165M107%
EBITDA-6.48M-207.96M3%
Gain YTD27.128-23.432-116%
P/E Ratio13.00N/A-
Revenue45.7M40.6M113%
Total Cash27.4M391M7%
Total Debt5.68M40.5M14%
FUNDAMENTALS RATINGS
PLX: Fundamental Ratings
PLX
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PLXZNTL
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 18 days ago
84%
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Ad is loading...
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MADRX26.44-0.15
-0.56%
Madison Dividend Income R6
AZNCX9.74-0.10
-1.02%
Virtus Income & Growth C
FGIRX42.35-0.75
-1.74%
Fidelity Advisor Growth & Income A
MLPSX88.73-1.67
-1.85%
ProFunds Mid Cap Value Svc
ECLCX28.77-0.64
-2.18%
Eaton Vance Growth C

PLX and

Correlation & Price change

A.I.dvisor tells us that PLX and ZNTL have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PLX and ZNTL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLX
1D Price
Change %
PLX100%
-1.65%
ZNTL - PLX
31%
Poorly correlated
-6.07%
CPRX - PLX
31%
Poorly correlated
-1.95%
ACET - PLX
31%
Poorly correlated
-2.66%
SNDX - PLX
31%
Poorly correlated
+2.44%
LXRX - PLX
31%
Poorly correlated
-2.20%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with MDGL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
-6.07%
MDGL - ZNTL
51%
Loosely correlated
-4.22%
ORMP - ZNTL
43%
Loosely correlated
-3.15%
NGNE - ZNTL
40%
Loosely correlated
+0.29%
NRIX - ZNTL
40%
Loosely correlated
-1.00%
VCYT - ZNTL
39%
Loosely correlated
-4.56%
More